Difficulty: Medium
Average Score: 69%
Practice
A 55-year-old woman is hospitalized for treatment of osteomyelitis. The infectious organism is found to be susceptible to gentamicin so she is started on a once-daily dose of intravenous gentamicin. Which of the following symptoms may be a signal to the physician to stop gentamicin therapy?
Correct answer
D
Rationale
Rationale:
The correct answer is D) Tinnitus. Tinnitus is a known side effect of gentamicin therapy and can be an early sign of ototoxicity, which is damage to the inner ear structures responsible for hearing and balance. It is crucial to monitor for tinnitus during gentamicin therapy as it may indicate potential hearing loss or other serious side effects.
Option A) Eosinophilia is not typically associated with gentamicin therapy and is more commonly seen in allergic reactions or parasitic infections.
Option B) Headache is a non-specific symptom and not a common side effect of gentamicin. It is less likely to be a signal to stop therapy unless accompanied by other concerning symptoms.
Option C) Nausea is a common side effect of gentamicin but alone may not be a signal to stop therapy unless severe or accompanied by other more serious symptoms.
Educational Context:
Understanding the potential side effects of chemotherapy drugs like gentamicin is crucial for healthcare professionals to ensure safe and effective patient care. Monitoring for early signs of adverse effects, such as tinnitus in the case of gentamicin, can help prevent further complications and improve patient outcomes. Educating healthcare providers on drug-specific side effects and monitoring parameters is essential for safe medication administration.
The correct answer is D) Tinnitus. Tinnitus is a known side effect of gentamicin therapy and can be an early sign of ototoxicity, which is damage to the inner ear structures responsible for hearing and balance. It is crucial to monitor for tinnitus during gentamicin therapy as it may indicate potential hearing loss or other serious side effects.
Option A) Eosinophilia is not typically associated with gentamicin therapy and is more commonly seen in allergic reactions or parasitic infections.
Option B) Headache is a non-specific symptom and not a common side effect of gentamicin. It is less likely to be a signal to stop therapy unless accompanied by other concerning symptoms.
Option C) Nausea is a common side effect of gentamicin but alone may not be a signal to stop therapy unless severe or accompanied by other more serious symptoms.
Educational Context:
Understanding the potential side effects of chemotherapy drugs like gentamicin is crucial for healthcare professionals to ensure safe and effective patient care. Monitoring for early signs of adverse effects, such as tinnitus in the case of gentamicin, can help prevent further complications and improve patient outcomes. Educating healthcare providers on drug-specific side effects and monitoring parameters is essential for safe medication administration.